000			03196nam a22003735i 4500
001			99818
003			DE-He213
005			20230110040152.0
007			cr nn 008mamaa
008			180227s2018 si | s |||| 0|eng d
020			_a9789811076329 _9
024	7		_a10.1007/978-981-10-7632-9 _2doi
040			_aES-MaUEC _bspa
050		4	_aRC632.H65 _bB43 2018 EB
100	1		_aBhargava, Seema _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _0http://id.loc.gov/authorities/names/no2011137231 _0http://viaf.org/viaf/179340158
245	1	4	_aThe Clinical Application of Homocysteine _cby Seema Bhargava.
264		1	_aSingapore _bSpringer International Publishing _c2018
300			_a1 recurso en línea (XIX, 96 páginas 19 ilustraciones a color)
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
505	0		_aIntroduction -- Discovery and metabolism -- Homocysteinemia and occlusive vascular disease --  Homocysteinemia and hypertension -- Homocysteinemia and its neurological effects -- Homocysteinemia in nephrology practice -- Homocysteinemia and oncology -- Homocysteinemia and otology -- Homocysteinemia and bones -- The body's inherent defence against homocysteinemia -- Homocysteine and epigenetics -- Food fortification.
520	3		_aThis book helps clinicians to optimally and appropriately utilize homocysteine levels in the diagnosis, prediction and management of and research into vascular disease and many other conditions. It also familiarizes readers with the pathophysiology and clinical implications of hyperhomocysteinemia. Laboratory investigations are gaining importance in the diagnosis and prognosis of patients, and as such, scientists and laboratorians are constantly attempting to identify new markers that will help in earlier diagnosis and better prognostication of conditions with high morbidity and mortality, as well as high prevalence. According to the WHO, developing countries are home to 80% of patients with coronary artery disease (CAD) and stroke - conditions with a mortality second only to cancer. Intensive research in these areas has resulted in the identification of homocysteine (declared the 'marker of the millennium') and several new markers for the diagnosis and prediction of CAD and stroke. The book is a valuable resource for clinicians and consultants in practice, as well as for postgraduate and undergraduate students of medicine, biotechnology and biochemistry.
650		7	_aBioquímica _2embne _9138639
650		7	_aOncología _2embne _9139207
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9789811076312
776	0	8	_iEdición impresa: _z9789811076336
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-7632-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490	0		_aMedicine (Springer-11650)
988			_aSpringer_Medicine_2018
998			_b01/2019 _dz _ef _feng _ggw _h0
999			_c99818 _d99818 _x1